Trial intelligence / Profile preview

ACTH vs Betamethasone for Acute Gout in Hospitalized Patients

NCT04306653Unknown

Sponsor
University of Patras
Start
Jan 2018
Primary completion
Apr 2020
Modality
Peptides
Countries
1
01

Overview

Randomised, open-label trial of Synacthen Depot in gout (2 arms), sponsored by University of Patras. Primary endpoint: Visual Analogue Scale for Pain at 5 days. Status: unknown.

02

Drugs

Synacthen Depot
03

Conditions

gout

Beyond the preview

Go deeper on NCT04306653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04306653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call